Cabaletta Bio CABA
NASDAQ CABA
$1.52 -0.02 (-1.30%)
At close: Oct 22, 2026 · 4:00 PM EDT

Cabaletta Bio (CABA) Long-Term Investments (2020)

Updated

Cabaletta Bio's Long-Term Investments came in at $1.33 million for Q3 2020, down 60.6% from the prior quarter.

Analysis

Cabaletta Bio (CABA) Long-Term Investments (2020) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,230.11 Bn 1,198.70 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 644.39 Bn 564.25 Bn 17.30 Bn -
3 AbbVie 503.52 Bn 476.68 Bn 12.70 Bn 266.00 Mn
4 Merck 363.29 Bn 317.72 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 298.23 Bn 262.62 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 267.53 Bn 241.29 Bn 12.86 Bn 297.00 Mn
7 Amgen 241.80 Bn 197.20 Bn 7.24 Bn -
8 Gilead Sciences 195.07 Bn 169.19 Bn 6.22 Bn -
9 Pfizer 173.33 Bn 120.28 Bn 10.94 Bn 1.56 Bn
10 Cabaletta Bio 257.71 Mn 32.61 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 1.33 Mn
Jun 30, 2020 3.38 Mn
API Access

Cabaletta Bio Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=CABA&period=max&api_key=YOUR_API_KEY